Pulmonx Corp (LUNG) has 4 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $177K. Most recent filing: Sept. 3, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 3, 2026 filed Sept. 1, 2026 | Lehman David Aaron General Counsel | −$32,395 | 14,334 | −4% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | French Glendon E. III President and CEO | −$94,653 | 41,882 | −4% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Radhakrishnan Srikanth Chief Science & Techn. Officer | −$32,194 | 14,245 | −4% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Rose Geoffrey Beran Chief Commercial Officer | −$17,807 | 7,879 | −2% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free